Management of Apnea in Late Preterm and Term Infants

NCT02408328 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Transition to new position

Conditions

Apnea

Interventions

DRUG: Caffeine citrate
DEVICE: Home monitor
OTHER: Continued inpatient monitoring until apnea resolution

Sponsor

Boston Children's Hospital